GSKNEUTRAL

EV/EBITDA

10.2x

Higher than 44% of Healthcare sector peers

Updated 167h ago

Sector Performance

44th percentile

GSK

10.2x

Sector Median

12.8x

Sector Avg

15.6x

📊

Deep Analysis

GSK’s current EV/EBITDA of 10.2x means that the enterprise value—the total market value of its equity plus debt minus cash—is about 10.2 times its earnings before interest, taxes, depreciation, and amortization, a measure of operating cash flow.

This figure sits below the healthcare sector median of 13.1x, placing GSK in the 42nd percentile among its sector peers, suggesting a relatively lower valuation compared to the typical peer. The trend data for this metric is not available, with both the year-over-year and quarter-over-quarter changes reported as N/A, so no recent direction can be inferred. Given the below-median valuation level combined with an unknown trend, the metric implies moderate opportunity if earnings remain stable, but carries uncertainty due to the lack of historical context. This EV/EBITDA reading supports the overall NEUTRAL verdict, as the discounted valuation is offset by the absence of trend information needed to confirm a clear catalyst.

Frequently Asked Questions

What does the EV/EBITDA tell investors about GSK?

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.

How is the EV/EBITDA calculated?

EV/EBITDA is calculated as: Enterprise Value / EBITDA.

How does GSK's EV/EBITDA compare to its sector?

GSK's EV/EBITDA of 10.2x compares to a Healthcare sector median of 12.8x, placing it in the 44th percentile.

Who are GSK's closest peers by EV/EBITDA?

The closest Healthcare peers by EV/EBITDA include: BDX (12.2x), CPRX (10.1x), ZBH (9.7x), BAX (9.4x), BIIB (8.8x).

The Formula

Enterprise Value / EBITDA

Why It Matters

A valuation multiple preferred by analysts for capital-intensive or leveraged businesses. Useful for cross-sector comparisons where earnings can be distorted by debt.